1. Home
  2. NRSN vs JL Comparison

NRSN vs JL Comparison

Compare NRSN & JL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • JL
  • Stock Information
  • Founded
  • NRSN 2017
  • JL 1985
  • Country
  • NRSN Israel
  • JL Hong Kong
  • Employees
  • NRSN N/A
  • JL N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • JL
  • Sector
  • NRSN Health Care
  • JL
  • Exchange
  • NRSN Nasdaq
  • JL NYSE
  • Market Cap
  • NRSN 17.8M
  • JL 13.0M
  • IPO Year
  • NRSN 2021
  • JL 2024
  • Fundamental
  • Price
  • NRSN $1.12
  • JL $3.92
  • Analyst Decision
  • NRSN Hold
  • JL
  • Analyst Count
  • NRSN 1
  • JL 0
  • Target Price
  • NRSN N/A
  • JL N/A
  • AVG Volume (30 Days)
  • NRSN 129.6K
  • JL 72.6K
  • Earning Date
  • NRSN 04-04-2025
  • JL 03-25-2025
  • Dividend Yield
  • NRSN N/A
  • JL N/A
  • EPS Growth
  • NRSN N/A
  • JL N/A
  • EPS
  • NRSN N/A
  • JL 0.54
  • Revenue
  • NRSN N/A
  • JL $32,831,195.00
  • Revenue This Year
  • NRSN N/A
  • JL N/A
  • Revenue Next Year
  • NRSN N/A
  • JL N/A
  • P/E Ratio
  • NRSN N/A
  • JL $7.20
  • Revenue Growth
  • NRSN N/A
  • JL 7.72
  • 52 Week Low
  • NRSN $0.51
  • JL $0.23
  • 52 Week High
  • NRSN $2.25
  • JL $13.41
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 51.47
  • JL 43.28
  • Support Level
  • NRSN $0.96
  • JL $3.79
  • Resistance Level
  • NRSN $1.17
  • JL $4.24
  • Average True Range (ATR)
  • NRSN 0.08
  • JL 0.42
  • MACD
  • NRSN 0.00
  • JL -0.07
  • Stochastic Oscillator
  • NRSN 66.24
  • JL 13.64

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About JL J-LONG GROUP LIMITED

J-Long Group Ltd is an established distributor in Hong Kong of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pullers and drawcords. It also offers a wide range of apparel solution services to cater to its customers' needs for reflective and non-reflective garment trims, ranging from market trend analysis, product design and development and production to quality control.

Share on Social Networks: